Centenary Institute hosts TB research symposium
The Centenary Institute has hosted the 2025 Annual Research Symposium of the ‘Centre of Research Excellence in Tuberculosis Elimination (TB-CRE)’.
New platform to evolve proteins for better therapies
Researchers from the Centenary Institute, in collaboration with the University of Sydney, have developed a powerful new tool to evolve proteins directly within mammalian cells, offering a more effective way to design medical treatments tailored to the human body.
New discovery could improve treatment for people with haemophilia A
Researchers from the Centenary Institute have uncovered a reason why some people with haemophilia A develop resistance to their critical treatment, paving the way for the development of more effective therapies.
Event shines spotlight on genetic heart disease in young people
The Centenary Institute has hosted a community event aimed to advance understanding of inherited heart disease and sudden cardiac death in young people.
Turning off protein may help prevent liver cancer
New research from the Centenary Institute has found that switching off a specific protein in liver cells may help prevent the early development of liver cancer.
New mRNA vaccine boosts immunity against TB
A study into the new vaccine’s effectiveness, published in eBioMedicine, was led by experts from the Sydney Infectious Diseases Institute at University of Sydney, the Centenary Institute and the Monash Institute of Pharmaceutical Science (MIPS) at Monash University.
